2015 | |
---|---|
Criterium: | Position: |
Overall Score: | > 1000 |
Networking Rank (Reputation): | > 1000 |
Total number of projects: 3
As coordinator: 0
As participant: 3
Sole participant: 0
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2021 | 0 | 5.999.999 | 841.759 | 1 | ||
2017 | 0 | 6.478.738 | 2.821.450 | 1 | ||
2015 | 0 | 5.913.080 | 800.814 | 1 |
Total number of partners: 36
Partner loyalty:
Frequent Partner: (> 2 projects): 6
Rare Partner: 30
Frequent / Rare Partner Ratio: 0.2
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2021-03-01 | NOVEL TREATMENT OF ACUTE ON CHRONIC LIVER FAILURE USING SYNERGISTIC ACTION OF G-CSF AND TAK-242 | A-TANGO | participant | 5.999.999 | 14 |
2017-01-01 | Development of DIALIVE, a novel Liver Dialysis Device for the treatment of patients with Acute on Chronic Liver Failure (ACLF) | ALIVER | participant | 6.478.738 | 11 |
2015-05-01 | Clinical evaluation of carbons of controlled porosity as a new therapeutic for the treatment of liver cirrhosis and non-alcoholic fatty liver disease. | CARBALIVE | participant | 5.913.080 | 14 |